ThermoGenesis Holdings - 26 Year Stock Price History | THMO

Historical daily share price chart and data for ThermoGenesis Holdings since 1995 adjusted for splits. The latest closing stock price for ThermoGenesis Holdings as of September 27, 2021 is 2.15.
  • The all-time high ThermoGenesis Holdings stock closing price was 5120.00 on November 26, 2004.
  • The ThermoGenesis Holdings 52-week high stock price is 4.45, which is 107% above the current share price.
  • The ThermoGenesis Holdings 52-week low stock price is 1.92, which is 10.7% below the current share price.
  • The average ThermoGenesis Holdings stock price for the last 52 weeks is 2.56.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
ThermoGenesis Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 2.6179 2.1900 3.9800 2.0400 2.1500 2.87%
2020 4.4321 4.3100 12.2100 1.7200 2.0900 -52.50%
2019 3.5196 2.7100 6.6300 2.3990 4.4000 64.86%
2018 11.2935 31.0000 37.8830 2.2990 2.6690 -91.10%
2017 32.6754 33.0000 48.1000 26.3000 30.0000 -13.04%
2016 34.9103 37.6400 62.0000 19.1000 34.5000 -5.27%
2015 146.2558 206.0000 220.0000 36.4200 36.4200 -82.15%
2014 298.3326 212.0000 564.0000 200.0000 204.0000 0.01%
2013 201.5465 170.0000 306.0000 143.0000 203.9800 21.42%
2012 183.7656 140.0400 258.0000 134.0000 168.0000 18.31%
2011 391.4122 764.0000 764.0000 142.0000 142.0000 -79.83%
2010 508.1515 471.9200 752.0000 352.0000 704.0000 52.54%
2009 482.9457 384.0000 672.0000 321.6000 461.5200 34.16%
2008 1065.2443 1384.0000 1632.0000 248.0000 344.0000 -72.78%
2007 2205.9445 3432.0000 3504.0000 1264.0000 1264.0000 -63.34%
2006 3358.6932 3912.0000 4016.0000 2728.0000 3448.0000 -10.77%
2005 3862.9063 5000.0000 5096.0000 2520.0000 3864.0000 -23.82%
2004 3856.7111 4080.0000 5120.0000 2848.0000 5072.0000 22.39%
2003 2308.1302 1576.0000 4552.0000 1200.0000 4144.0000 152.68%
2002 1535.6444 1888.0000 2344.0000 880.0000 1640.0000 -14.94%
2001 1704.8194 1250.4000 2400.0000 1176.0000 1928.0000 37.71%
2000 1804.5302 1900.0000 3300.0000 1024.8000 1400.0000 -26.32%
1999 1446.9270 1575.2000 2450.4000 875.2000 1900.0000 18.75%
1998 1717.3708 2624.8000 2800.0000 600.0000 1600.0000 -36.00%
1997 2675.3960 3200.0000 3300.0000 1850.4000 2500.0000 -19.46%
1996 2798.6995 1504.0000 4496.0000 1248.0000 3104.0000 113.19%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.026B $0.010B
ThermoGenesis Holdings Inc. develops, commercializes and markets automated technologies for CAR-T and other cell-based therapies. The company markets solutions for automated clinical biobanking, point-of-care applications and automation for immuno-oncology. ThermoGenesis Holdings Inc., formerly known as Cesca Therapeutics Inc., is based in Rancho Cordova, California.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29